Foresite Capital Management Iii, LLC Aclaris Therapeutics, Inc. Transaction History

Foresite Capital Management Iii, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$12.27 - $18.49 $24 Million - $36.1 Million	-1,954,904 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$5.86 - $27.73 $1.96 Million - $9.28 Million	334,660 Added 20.65%	1,954,904 $49.3 Million
Q4 2020 Feb 16, 2021	BUY	$2.65 - $7.61 $2.48 Million - $7.12 Million	935,332 Added 136.56%	1,620,244 $10.5 Million
Q3 2020 Nov 13, 2020	BUY	$1.5 - $2.71 $1.03 Million - $1.86 Million	684,912 New	684,912 $1.76 Million
Q1 2019 May 14, 2019	SELL	$5.63 - $7.84 $1.5 Million - $2.08 Million	-265,694 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$6.3 - $15.4 $294,046 - $718,779	-46,674 Reduced 14.94%	265,694 $1.96 Million
Q1 2018 May 15, 2018	BUY	$17.08 - $25.64 $1.7 Million - $2.55 Million	99,418 Added 46.69%	312,368 $5.47 Million
Q4 2017 Feb 13, 2018	SELL	$21.47 - $27.8 $1.07 Million - $1.39 Million	-50,000 Reduced 19.02%	212,950 $5.25 Million
Q3 2017 Nov 13, 2017	BUY	$23.02 - $28.8 $6.05 Million - $7.57 Million	262,950	262,950 $6.79 Million

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $255M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Foresite Capital Management Iii, LLC, based on Form 13F filings with the SEC.

Stay updated on Foresite Capital Management Iii, LLC with notifications on news.